Peripheral neuropathy: differential diagnosis and management
- PMID: 20353146
Peripheral neuropathy: differential diagnosis and management
Abstract
Peripheral neuropathy has a variety of systemic, metabolic, and toxic causes. The most common treatable causes include diabetes mellitus, hypothyroidism, and nutritional deficiencies. The diagnosis requires careful clinical assessment, judicious laboratory testing, and electrodiagnostic studies or nerve biopsy if the diagnosis remains unclear. A systematic approach begins with localization of the lesion to the peripheral nerves, identification of the underlying etiology, and exclusion of potentially treatable causes. Initial blood tests should include a complete blood count, comprehensive metabolic profile, and measurement of erythrocyte sedimentation rate and fasting blood glucose, vitamin B12, and thyroid-stimulating hormone levels; specialized tests should be ordered if clinically indicated. Lumbar puncture and cerebrospinal fluid analysis may be helpful in the diagnosis of Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Electrodiagnostic studies, including nerve conduction studies and electromyography, can help in the differentiation of axonal versus demyelinating or mixed neuropathy. Treatment should address the underlying disease process, correct any nutritional deficiencies, and provide symptomatic treatment.
Similar articles
-
An algorithm for the evaluation of peripheral neuropathy.Am Fam Physician. 1998 Feb 15;57(4):755-64. Am Fam Physician. 1998. PMID: 9490998 Review.
-
Peripheral Neuropathy: Evaluation and Differential Diagnosis.Am Fam Physician. 2020 Dec 15;102(12):732-739. Am Fam Physician. 2020. PMID: 33320513
-
HIV and peripheral neuropathy.J Int Assoc Physicians AIDS Care. 1995 Jul;1(6):30-3. J Int Assoc Physicians AIDS Care. 1995. PMID: 11362726
-
Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features.Muscle Nerve. 1989 Jun;12(6):435-51. doi: 10.1002/mus.880120602. Muscle Nerve. 1989. PMID: 2657418 Review.
-
Contribution of nerve biopsy to unclassified neuropathy.Eur Neurol. 2007;57(2):86-90. doi: 10.1159/000098057. Epub 2006 Dec 15. Eur Neurol. 2007. PMID: 17179710
Cited by
-
Tapentadol extended release in the management of peripheral diabetic neuropathic pain.Ther Clin Risk Manag. 2015 Jan 14;11:95-105. doi: 10.2147/TCRM.S32193. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 25609974 Free PMC article. Review.
-
Effects of omalizumab therapy on peripheral nerve functions: short observational study.Postepy Dermatol Alergol. 2019 Apr;36(2):211-216. doi: 10.5114/ada.2018.74834. Epub 2018 Apr 3. Postepy Dermatol Alergol. 2019. PMID: 31320856 Free PMC article.
-
Peripheral polyneuropathy from electrodiagnostic tests: a 10-year etiology and neurophysiology overview.Arq Neuropsiquiatr. 2022 Mar;80(3):270-279. doi: 10.1590/0004-282X-ANP-2020-0561. Arq Neuropsiquiatr. 2022. PMID: 34816968 Free PMC article.
-
Origins of Phantom Limb Pain.Mol Neurobiol. 2018 Jan;55(1):60-69. doi: 10.1007/s12035-017-0717-x. Mol Neurobiol. 2018. PMID: 28921474 Review.
-
Network Meta-analysis of Randomized Controlled Trials Assessing Neuromodulation Therapies for Painful Diabetic Neuropathy.Neurol Ther. 2025 Aug;14(4):1355-1382. doi: 10.1007/s40120-025-00759-1. Epub 2025 May 13. Neurol Ther. 2025. PMID: 40358907 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical